Early and individualized goal-directed therapy for trauma-induced coagulopathy - Test2 - elhamkhani - TriplyDB

Early and individualized goal-directed therapy for trauma-induced coagulopathy

Early and individualized goal-directed therapy for trauma-induced coagulopathy

http://www.wikidata.org/entity/Q26853422

about

Viscoelastic Methods of Blood Clotting Assessment - A Multidisciplinary Review Massive hemorrhage management-a best evidence topic report TEG and ROTEM: technology and clinical applications [Hemoglobin-oriented and coagulation factor-based algorithm : Effect on transfusion needs and standardized mortality rate in massively transfused trauma patients].Micro-elastometry on whole blood clots using actuated surface-attached posts (ASAPs).The trauma patient in hemorrhagic shock: how is the C-priority addressed between emergency and ICU admission?Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission.Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study.Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients Trauma-Induced Coagulopathy Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study.Comparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox ®) versus thromboelastometry (ROTEM ®).Preoperative Thromboelastometry as a Predictor of Transfusion Requirements during Adult Living Donor Liver Transplantation Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.Interventional Algorithms for the Control of Coagulopathic Bleeding in Surgical, Trauma, and Postpartum Settings: Recommendations From the Share Network Group Critical care considerations in the management of the trauma patient following initial resuscitation.Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test.The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.New evidence in trauma resuscitation - is 1:1:1 the answer?Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.Use of plasma in the management of central nervous system bleeding: evidence-based consensus recommendations.Bleeding management for pediatric craniotomies and craniofacial surgery.State of the art: massive transfusion.Management of traumatic haemorrhage--the European perspective.Thromboelastometry-guided therapy of massive gastrointestinal bleeding in a 12-year old boy with severe Graft-versus-Host disease Coagulation factor concentrate-based therapy for remote damage control resuscitation (RDCR): a reasonable alternative?Economic aspects of intraoperative coagulation management targeting higher fibrinogen concentrations during major craniosynostosis surgery.Diversity in clinical management and protocols for the treatment of major bleeding trauma patients across European level I Trauma Centres.Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model.[Early viscoelasticity-based coagulation therapy for severely injured bleeding patients: Report of the consensus group on the consensus conference 2014 for formulation of S2k guidelines].Prevalence and Associated Factors of Acute Traumatic Coagulopathy; a Cross Sectional Study.Practical understanding of hemostasis and approach to the bleeding patient in the OR The impact of early thromboelastography directed therapy in trauma resuscitation.iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial Editorial: facts, figures and the future.ROTEM®-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice, Italy.

P2860

Q26781050-56BB509F-553B-45B5-9557-4E5A39499C9E Q26801295-62E37B65-0096-4E6F-96CB-4DA1E54119A1 Q26830530-DB85990C-A5C7-47B5-B8EB-4F5E62A3B62B Q30316055-EE5D5754-FBF8-4309-A822-764E41F4F728 Q30388919-10036210-BE42-4CB5-BF03-DF2BE8AFFF56 Q33404633-31141B5C-B0F5-4333-8D32-D1948A9BE31D Q33749953-5D2F8BFD-FEFF-41F3-9719-3469AEDCE2BC Q33751742-A3EBA12B-9402-458A-A81A-72BFE6C717FE Q33810788-CA263104-C324-4B3F-9D2C-00E31A8E87D0 Q34485905-DB54E211-5853-46E0-8429-8AFDA9F6EBA3 Q34889509-F836E3F1-8CE9-46C6-A4AC-04D989FE85D4 Q35218708-A4D11122-B9DD-4D8D-8D1A-B4794A279BD1 Q35318068-B40D6DF3-38D2-404E-A7DE-39235E4B2EAC Q35631323-243C9FEA-3E4B-4CDE-8188-7AC86B262FBA Q36396010-5BF3FEF4-4B1D-40B3-A2CB-88A89C90FE54 Q36543599-CAEFC0AE-65D1-47BB-A52A-0C6FB8CE1F71 Q36594487-95342AF6-CFE7-4E35-9D87-56FF9D0872FD Q36956162-774D1B4A-804E-4D5E-9FA7-3B16A3837715 Q37059236-7596C393-9F19-4A49-A5BE-0C11CADFA004 Q37306739-A607E8D5-ABE5-4705-AADA-2EC63CD8604F Q37518149-CA3F141B-D191-49B1-9AD1-15C5A59AF2BE Q37660537-2D374245-57A4-4B6A-8BA2-0FE6BD148192 Q37731832-1CFC2A00-92E9-4830-B7C4-341D8CF06431 Q38151867-0219766C-7E40-4D2F-ADE9-4CE63E0ABC4B Q38171401-890536B9-14A2-47D5-8B1C-D471A3AE0D99 Q38210761-3B0E6EC0-C87F-4BE1-9381-F90867079411 Q38217006-2006087F-3816-4EB5-8153-E0A5073CB080 Q38273794-6C339ED2-61BE-411E-9863-C3FE05DE7F43 Q39218558-7908B399-4B88-44D8-ADA6-31AE8C6C7DF5 Q39834024-31E2DF16-B370-4683-8C92-69DF92A718A7 Q40441737-B0EC8264-A4F5-4C96-AFE5-3445CFB5471C Q40476671-A25BCB72-FB0B-4C40-9D7A-F54273455E36 Q40967575-A1E9715C-229E-444A-8759-7BD054FBE9C0 Q41619894-6DA1A310-CF17-455A-8A53-29306B6ABC02 Q41624242-1CC7065C-CE7F-473F-88AE-562CC3780988 Q41911491-EE05259F-13F1-4C83-B14F-E95EF5CE71A3 Q42078012-035993A1-E2F8-466D-A0FB-658D60A49448 Q42672681-A58E4D9E-E3BF-42EA-BF63-B95D467A7F37 Q43108395-4B0B383A-C9C8-423A-A657-08CAD2409B0C Q43241205-D1DAF6E0-AFEE-4674-AB72-2BC3763919AB

P2860

Early and individualized goal-directed therapy for trauma-induced coagulopathy

http://www.wikidata.org/entity/Q26853422

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@ast

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@en

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@nl

type

label

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@ast

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@en

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@nl

prefLabel

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@ast

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@en

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@nl

P1433

Q26853422-408C0799-09B2-4DF9-86AF-D7FD68C6E399

P1476

Q26853422-03DA5E3C-0DCF-489E-A4BA-AA4E5ED87178

P2093

Q26853422-2CF6F216-A75E-424D-BC47-3EC757753957

Q26853422-3B331D21-D730-4DA6-AFBE-638D859918BA

Q26853422-4C296732-D10C-4844-8CBC-BEDD8DDB01F3

Q26853422-5E84C3A6-05C2-46AB-9F66-DBCC1C5168A8

Q26853422-82E213A9-C994-465B-8617-5C5C1443131A

P2860

Q26853422-010857F2-9862-4E49-BB35-BCBBF1C795C4

Q26853422-0172847B-6F7D-46E0-BB8B-FDB8FE8E57C2

Q26853422-03E2CF22-8D25-4B97-A4F6-9B884C1FDB70

Q26853422-0B40C231-C76A-4704-B43C-912788F1CCC7

Q26853422-1237489D-0AFF-470C-B24D-D594E94C78DF

Q26853422-12D3144A-E4AC-453E-9F94-6DA32D65A3E2

Q26853422-1354A1E5-237A-4E1E-91C0-3B8EC4BDDF18

Q26853422-16754FDF-B268-42C8-9947-066D4C6B0FFA

Q26853422-171EE942-5D22-4532-B370-1D3470EB8AF9

Q26853422-17A660F1-086C-4CCF-A2E9-B53A757D086E

P2888

Q26853422-9CC28DF0-0D48-4825-A4C8-71691633CC46

P304

Q26853422-DF4CA404-F5DA-42FD-B876-C2B591761732

P31

Q26853422-2EC4063E-7A7A-4E79-AD56-E0307E3B7F22

P356

Q26853422-7DD7190D-2216-4327-BDCD-EF0AEAF5381F

P407

Q26853422-6FF6C480-9B4A-4B9C-BF99-0CCC421BFE1B

P478

Q26853422-1F72A769-9EA2-498A-ACA3-B4C777C38B02

P577

Q26853422-10CBF8DF-041F-43D1-9497-5FB3CDF7FC2C

P5875

Q26853422-D871AB4D-48C6-4D5B-9307-0CAE2C78389D

P6179

Q26853422-661CBA7B-A6C7-483C-A6B6-638BE7651F38

P698

Q26853422-BEAC20F6-86A7-424B-A3B0-2DC58FEF7A4E

P932

Q26853422-1820290C-EDBE-4137-8967-F2DAEC074156

P356

1757-7241-20-15

P1433

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

P1476

Early and individualized goal-directed therapy for trauma-induced coagulopathy

@en

P2093

Cristina Solomon

http://www.w3.org/2001/XMLSchema#string

Herbert Schöchl

http://www.w3.org/2001/XMLSchema#string

Klaus Görlinger

http://www.w3.org/2001/XMLSchema#string

Marc Maegele

http://www.w3.org/2001/XMLSchema#string

Wolfgang Voelckel

http://www.w3.org/2001/XMLSchema#string

P2860

The epidemiology and modern management of traumatic hemorrhage: US and international perspectives

Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?

A cell-based model of hemostasis

Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood

Epidemiology of trauma deaths: a reassessment

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

A predictive model for massive transfusion in combat casualty patients.

Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).

Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.

Management of bleeding following major trauma: an updated European guideline.

P2888

1757-7241-20-15

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-7241-20-15

http://www.w3.org/2001/XMLSchema#string

P407

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221860743

http://www.w3.org/2001/XMLSchema#string

P6179

1040899086

http://www.w3.org/2001/XMLSchema#string

P698

22364525

http://www.w3.org/2001/XMLSchema#string

P932

3306198

http://www.w3.org/2001/XMLSchema#string